Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21299239rdf:typepubmed:Citationlld:pubmed
pubmed-article:21299239lifeskim:mentionsumls-concept:C2936295lld:lifeskim
pubmed-article:21299239lifeskim:mentionsumls-concept:C1099354lld:lifeskim
pubmed-article:21299239lifeskim:mentionsumls-concept:C1160466lld:lifeskim
pubmed-article:21299239lifeskim:mentionsumls-concept:C1328819lld:lifeskim
pubmed-article:21299239pubmed:issue5lld:pubmed
pubmed-article:21299239pubmed:dateCreated2011-2-25lld:pubmed
pubmed-article:21299239pubmed:abstractTextWe have previously demonstrated that conjugation of small molecule ligands to small interfering RNAs (siRNAs) and anti-microRNAs results in functional siRNAs and antagomirs in vivo. Here we report on the development of an efficient chemical strategy to make oligoribonucleotide-ligand conjugates using the copper-catalyzed azide-alkyne cycloaddition (CuAAC) or click reaction. Three click reaction approaches were evaluated for their feasibility and suitability for high-throughput synthesis: the CuAAC reaction at the monomer level prior to oligonucleotide synthesis, the solution-phase postsynthetic "click conjugation", and the "click conjugation" on an immobilized and completely protected alkyne-oligonucleotide scaffold. Nucleosides bearing 5'-alkyne moieties were used for conjugation to the 5'-end of the oligonucleotide. Previously described 2'- and 3'-O-propargylated nucleosides were prepared to introduce the alkyne moiety to the 3' and 5' termini and to the internal positions of the scaffold. Azido-functionalized ligands bearing lipophilic long chain alkyls, cholesterol, oligoamine, and carbohydrate were utilized to study the effect of physicochemical characteristics of the incoming azide on click conjugation to the alkyne-oligonucleotide scaffold in solution and on immobilized solid support. We found that microwave-assisted click conjugation of azido-functionalized ligands to a fully protected solid-support bound alkyne-oligonucleotide prior to deprotection was the most efficient "click conjugation" strategy for site-specific, high-throughput oligonucleotide conjugate synthesis tested. The siRNA conjugates synthesized using this approach effectively silenced expression of a luciferase gene in a stably transformed HeLa cell line.lld:pubmed
pubmed-article:21299239pubmed:languageenglld:pubmed
pubmed-article:21299239pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21299239pubmed:citationSubsetIMlld:pubmed
pubmed-article:21299239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21299239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21299239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21299239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21299239pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21299239pubmed:statusMEDLINElld:pubmed
pubmed-article:21299239pubmed:monthMarlld:pubmed
pubmed-article:21299239pubmed:issn1520-6904lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:GillF TFTlld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:ManoharanMuth...lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:SekineMitsuoMlld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:MaierMartin...lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:YamadaTakeshi...lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:RajeevKallant...lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:MatsudaShigeo...lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:AlamMd...lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:CharisseKlaus...lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:PengChang...lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:JayaprakashK...lld:pubmed
pubmed-article:21299239pubmed:authorpubmed-author:AddepalliHari...lld:pubmed
pubmed-article:21299239pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21299239pubmed:day4lld:pubmed
pubmed-article:21299239pubmed:volume76lld:pubmed
pubmed-article:21299239pubmed:ownerNLMlld:pubmed
pubmed-article:21299239pubmed:authorsCompleteYlld:pubmed
pubmed-article:21299239pubmed:pagination1198-211lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:meshHeadingpubmed-meshheading:21299239...lld:pubmed
pubmed-article:21299239pubmed:year2011lld:pubmed
pubmed-article:21299239pubmed:articleTitleVersatile site-specific conjugation of small molecules to siRNA using click chemistry.lld:pubmed
pubmed-article:21299239pubmed:affiliationDrug Discovery, Alnylam Pharmaceuticals, Cambridge, Massachusetts 02142, USA.lld:pubmed
pubmed-article:21299239pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21299239pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed